Mucodel Pharma LLC
2110 Rockglen Lane
Greensboro
North Carolina
United States
Tel: 336- 944-4677
Website: http://www.exonal.com/
Email: info@mucodel.com
About Mucodel Pharma LLC
The mission of Mucodel is to develop improved rescue therapies that are oromucosally administered. Mucodel’s proprietary Co-Gel technology allows for oromucosal administration of existing drugs that would not otherwise be amenable to oromucosal delivery. Mucodel’s Co-Gel platform enables more convenient products and offers tangible therapeutic benefits to patients.YEAR FOUNDED:
2014
LEADERSHIP:
Founder & CEO: Madhu Hariharan
PIPELINE:
Please click here for Mucodel's pipeline.
2 articles about Mucodel Pharma LLC
-
Mucodel Pharma LLC Announces Successful Completion of Clinical Study of its Co-Gel Intranasal Naloxone Formulation
12/11/2017
The tested intranasal formulation employs Mucodel’s Co-Gel platform for the mucosal delivery of pharmaceutically active agents.
-
Mucodel Pharma Announces Successful Completion Of Buccal Naloxone Pilot Clinical Study
9/21/2016